Sabine Seiler

The University of Texas Southwestern Medical Center

Papers

Total Citations

H-Index

About

Sabine Seiler is a radiation oncologist whose research focuses on advancing breast cancer treatment through innovative, less invasive radiotherapy techniques. Her most notable contribution is the early results of a Phase I pre-operative single fraction ablative trial for early stage breast cancer, a groundbreaking study that explores the feasibility and safety of delivering a single, high-dose radiation treatment before surgery. This work, published in 2023, has already garnered 4 citations, signaling its potential to reshape clinical paradigms by reducing treatment burden and improving patient outcomes. Seiler’s research sits at the intersection of precision oncology and surgical oncology, aiming to minimize toxicity while maximizing tumor control. Her commitment to translating early-phase trial data into practice underscores her role as a forward-thinking clinician-scientist. By pioneering single-fraction approaches, Seiler is helping to pave the way for shorter, more patient-friendly breast cancer therapies, making her a key voice in the evolution of modern radiotherapy.